Alnylam Pharmaceuticals (ALNY.MX) Q2 2014 Earnings

8MayConfirmed
Q3 2013
Q4 2013
Q1 2014
Q2 2014
-7.64
-6.31
-4.98
-3.65

Details

Expected EPS
-7.63932
Actual EPS
-5.049720000000001
Surprise EPS
2.59
Surprise Percent
+33.9%

Description

Alnylam Pharmaceuticals (ALNY.MX) has reported earnings of -5.049720000000001 per share for Q2 2014.

0 Comments

Share your thoughts